BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our Industry eNewsletter FREE email:    
 Investor News
Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings
Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions 
Start-Ups
IPO News
IPO
 


Clinical - Discontinued
Johnson & Johnson (JNJ) Halts Development Of Botox Rival, Axes Staffers 4/14/2014 7:14:10 AM    More...
Forest Laboratories, Inc. (FRX) To Discontinue NAMENDA® Tablets, Focus On Once-Daily NAMENDA XR® 2/17/2014 6:32:23 AM    More...
Sanofi (France) (SAN.PA) Suffers Another Setback, Ditches Late-Stage Bone Marrow Cancer Drug 11/18/2013 7:03:54 AM    More...
Imprimis Pharmaceuticals (immy) to Shift Focus, Discontinues Impracor Phase 3 Program to Focus on Other Areas 11/6/2013 9:06:43 AM    More...
ImmunoGen, Inc. (IMGN) Discontinues Study as Lung Cancer Drug Flops; Stock Crashes -18.97%% at Market Close (November 5, 2013) 11/5/2013 7:22:00 AM    More...
Ariad Pharmaceuticals, Inc. (ARIA) Discontinues Phase 3 Study of Cancer Drug Iclusig; Shares Decimated, Falls -40.67% at Market Close (October 18, 2013) 10/18/2013 8:07:51 AM    More...
Medivir AB (MVIRb.F), Daewoong Pharmaceutical Co., Ltd. Discontinue Hepatitis B Drug Development 9/6/2013 6:54:34 AM    More...
Medivir AB (MVIRb.F) Makes Strategic Decision to Discontinue its NS5A Inhibitor Program 8/15/2013 9:45:00 AM    More...
Albany Molecular Research, Inc. (AMRI) (AMRI): Bristol-Myers Squibb Company (BMY) Stops Development of Depression Drug 8/13/2013 7:19:58 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) Ditches Rheumatoid Arthritis Drug After Phase 2 Trial Disappoints 8/5/2013 7:02:11 AM    More...
Higher Death Rates Force Celgene Corporation (CELG) to End Blood Cancer Trial 7/18/2013 7:14:14 AM    More...
Roche (RHHBY) Halts Diabetes Drug Trial in Blow to Pipeline 7/10/2013 7:37:31 AM    More...
Roche (RHHBY) Backs Out on Seaside Therapeutics Drug Trial for Fragile X. Parents Dismayed 6/10/2013 7:59:45 AM    More...
Sanofi (France) (SAN.PA) Pulls the Plug on Two Late-Stage Drugs, Plans $285 Million Charge 6/3/2013 7:59:51 AM    More...
Pfizer Inc. (PFE) Halts Study of Non-Hodgkin's Lymphoma Drug 5/21/2013 6:46:06 AM    More...
1234567
 

//-->